Human retinal organoids with an OPA1 mutation are defective in retinal ganglion cell differentiation and function
Stem Cell Reports · 2024
DOI: 10.1016/j.stemcr.2023.11.004 ↗Kurz gefasst
Fachartikel in der Zeitschrift Stem Cell Reports, 2024. Verfasst von Qiannan Lei und 3 weiteren Autor:innen. Beteiligte Einrichtung: State Key Laboratory of Ophthalmology, Zhongshan Ophthalmic Center, Sun Yat-sen University, Guangdong Provincial Key Laboratory of Ophthalmology and …. Hauptthemen laut MEDLINE: Retinal Ganglion Cells, Optic Atrophy, Autosomal Dominant. Die Arbeit wurde bisher 26-mal zitiert (Crossref) und nennt 55 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Ministry of Science and Technology of the People's Republic of China, Science and Technology Planning Project of Guangdong Province, State Key Laboratory of Ophthalmology.
Abstract (Originalsprache)
Autosomal dominant optic atrophy (ADOA), mostly caused by heterozygous OPA1 mutations and characterized by retinal ganglion cell (RGC) loss and optic nerve degeneration, is one of the most common types of inherited optic neuropathies. Previous work using a two-dimensional (2D) differentiation model of induced pluripotent stem cells (iPSCs) has investigated ADOA pathogenesis but failed to agree on the effect of OPA1 mutations on RGC differentiation. Here, we use 3D retinal organoids capable of mimicking in vivo retinal development to resolve the issue. We generated isogenic iPSCs carrying the hotspot OPA1 c.2708_2711delTTAG mutation and found that the mutant variant caused defective initial and terminal differentiation and abnormal electrophysiological properties of organoid-derived RGCs. Moreover, this variant inhibits progenitor proliferation and results in mitochondrial dysfunction. These data demonstrate that retinal organoids coupled with gene editing serve as a powerful tool to definitively identify disease-related phenotypes and provide valuable resources to further investigate ADOA pathogenesis and screen for ADOA therapeutics.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- State Key Laboratory of Ophthalmology, Zhongshan Ophthalmic Center, Sun Yat-sen University, Guangdong Provincial Key Laboratory of Ophthalmology and Visual Science, Guangzhou 510060, China.
- State Key Laboratory of Ophthalmology, Zhongshan Ophthalmic Center, Sun Yat-sen University, Guangdong Provincial Key Laboratory of Ophthalmology and Visual Science, Guangzhou 510060, China; Guangdong Provincial Key Labo…
Förderung
- Ministry of Science and Technology of the People's Republic of China
- Science and Technology Planning Project of Guangdong Province
- State Key Laboratory of Ophthalmology
- National Natural Science Foundation of China
- Scientific and Technological Planning Project of Guangzhou City
Zitieren
APA
Lei, Q., Xiang, K., Cheng, L., & Xiang, M. (2024). Human retinal organoids with an OPA1 mutation are defective in retinal ganglion cell differentiation and function. Stem Cell Reports. https://doi.org/10.1016/j.stemcr.2023.11.004
Vancouver
Lei Q, Xiang K, Cheng L, Xiang M. Human retinal organoids with an OPA1 mutation are defective in retinal ganglion cell differentiation and function. Stem Cell Reports. 2024. doi:10.1016/j.stemcr.2023.11.004
BibTeX
@article{Lei2024,
author = {Lei, Qiannan and Xiang, Kangjian and Cheng, Lin and Xiang, Mengqing},
title = {Human retinal organoids with an OPA1 mutation are defective in retinal ganglion cell differentiation and function},
journal = {Stem Cell Reports},
year = {2024},
doi = {10.1016/j.stemcr.2023.11.004}
}
EUVIMED